<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR60" class="ref">
 <label class="label">60.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Singh</surname>
    <given-names class="given-names">SK</given-names>
   </name>
   <name class="name">
    <surname class="surname">Afonina</surname>
    <given-names class="given-names">N</given-names>
   </name>
   <name class="name">
    <surname class="surname">Awwad</surname>
    <given-names class="given-names">M</given-names>
   </name>
   <name class="name">
    <surname class="surname">Bechtold-Peters</surname>
    <given-names class="given-names">K</given-names>
   </name>
   <name class="name">
    <surname class="surname">Blue</surname>
    <given-names class="given-names">JT</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chou</surname>
    <given-names class="given-names">D</given-names>
   </name>
   <etal class="etal"/>
  </person-group>
  <article-title class="article-title">An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics</article-title>
  <source class="source">J Pharm Sci</source>
  <year class="year">2010</year>
  <volume class="volume">99</volume>
  <issue class="issue">8</issue>
  <fpage class="fpage">3302</fpage>
  <lpage class="lpage">3321</lpage>
  <?supplied-pmid 20310025?>
  <pub-id pub-id-type="pmid" class="pub-id">20310025</pub-id>
 </element-citation>
</ref>
